Crown Advisors Management’s Checkpoint Therapeutics CKPT Stock Holding History

Crown Advisors Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200,000	Closed	-$808K	–	41
2025 Q1	$808K	Buy	+200,000	New	+$667K	0.71%	37

Crown Advisors Management's CKPT Position: Q2 2025 in Review

Crown Advisors Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 200,000 shares — an estimated $808K sold.

Crown Advisors Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $808K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Crown Advisors Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Crown Advisors Management sold 200,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $808K.
Crown Advisors Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Crown Advisors Management's Checkpoint Therapeutics position peaked at $808K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Crown Advisors Management's 13F filing for Q2 2025, filed 5 Aug 2025.